Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review

The search for clinically effective antivirals against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is ongoing. Repurposing of drugs licensed for non–coronavirus disease 2019 (COVID-19) indications has been extensively investigated in laboratory models and in clinical studies wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Mitre, María Patricia, Tong, Steven Y. C., Denholm, Justin T., Dore, Gregory J., Bowen, Asha C., Lewin, Sharon R., Venkatesh, Balasubramanian, Hills, Thomas E., McQuilten, Zoe, Paterson, David L., Morpeth, Susan C., Roberts, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425784/
https://www.ncbi.nlm.nih.gov/pubmed/36040613
http://dx.doi.org/10.1007/s40262-022-01170-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425784/
https://www.ncbi.nlm.nih.gov/pubmed/36040613
http://dx.doi.org/10.1007/s40262-022-01170-x

Ejemplares similares